Gross Margin: A company's total sales revenue minus its cost of goods sold, divided by the total sales revenue, expressed as a percentage. Calculated as: Gross Income / Total Revenues
Coeptis Therapeutics Holdings, Inc. (COEP) had Gross Margin of 94.76% for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
$0.86M |
|
$-2.59M |
|
$0.05M |
|
$0.82M |
|
$2.85M |
|
$-1.99M |
|
$0.37M |
|
$-1.62M |
|
$-1.46M |
|
$-1.62M |
|
$-1.62M |
|
$-1.62M |
|
$-1.46M |
|
$-1.99M |
|
$-1.69M |
|
4.23M |
|
4.23M |
|
$0.05 |
|
$0.05 |
|
| Balance Sheet Financials | |
$7.35M |
|
$0.01M |
|
$8.80M |
|
$16.15M |
|
$1.77M |
|
$0.15M |
|
$0.32M |
|
$2.09M |
|
$14.07M |
|
$13.71M |
|
$14.07M |
|
5.75M |
|
| Cash Flow Statement Financials | |
$-8.60M |
|
-- |
|
$13.74M |
|
$0.53M |
|
$5.67M |
|
$5.14M |
|
$5.71M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
4.16 |
|
-- |
|
-- |
|
0.01 |
|
0.02 |
|
|
Gross Margin |
94.76% |
-230.65% |
|
-230.65% |
|
-- |
|
-188.26% |
|
-299.90% |
|
$-8.60M |
|
-- |
|
-- |
|
-- |
|
0.05 |
|
-- |
|
117.32 |
|
0.77 |
|
-11.54% |
|
-11.84% |
|
-10.05% |
|
-11.41% |
|
$2.45 |
|
$-2.03 |
|
$-2.03 |
|